Biotech Acquisition Company
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Biotech Acquisition Company's balance sheet done over the years? Its assets were worth $230 last year, which is less than in the previous period. 12% of Biotech Acquisition Company’s total assets is currently financed by debt. Its liabilities reached the amount of $27, which means an decrease by -100% compared compared to last year.
Debt to Assets
| 2020 | 89500 | 69.5K | 77.65% |
|---|---|---|---|
| 2021 | 230 | 27 | 11.74% |
BIOTW Balance Sheet (2020 – 2021)
| 2021 | 2020 | |
|---|---|---|
Assets | ||
Current assets: | ||
Cash and cash equivalents | 0 | 0 |
Short term investments | 0 | 0 |
Net receivables | 0 | 0 |
Inventory | 0 | 0 |
Other current assets | 0 | 0 |
Total current assets | 0 | 0 |
Non-current assets: | ||
Property, Plant and Equipment | 0 | 0 |
Goodwill | 0 | 0 |
Intangible assets | 0 | 0 |
Long term investments | 230 | 0 |
Other non-current assets | 0 | 0 |
Total non-current assets | 230 | 0 |
Total assets | 230 | 89.5K |
Liabilities | ||
| Current liabilities: | ||
Accounts payable | ||
Deferred revenue | 0 | 0 |
Short term debt | 0 | 69.5K |
Total current liabilities | 0 | 69.5K |
| Non-current liabilities: | ||
Long term debt | 0 | 0 |
Deferred tax | 0 | 0 |
Other non-current liabilities | 27 | 0 |
Total non-current liabilities | 27 | 0 |
Total liabilities | 27 | 69.5K |
| Data source | Data source |